Moffitt Cancer Center and Fulgent Pharma form a strategic partnership

Moffitt Cancer Center, a Tampa-based cancer treatment and research center, and Fulgent Pharma, a subsidiary of Fulgent Genetics (NASDAQ: FLGT) and a leading nanobiotechnology company specializing in innovative cancer therapeutics,